Skip to main content

Pursuing advancement together

Join us at the American Society of Pain and Neuroscience (ASPN) 2022 Annual Conference

July 14 – 17, 2022, Miami, FL
Follow us on LinkedIn and use #ASPN2022 to join the conversation.


Upcoming events

Come see Boston Scientific at ASPN 2022

Visit us at Booth #502 to learn more about Cognita™ Practice Optimization and our family of neuromodulation solutions.  

Request more information


Clinical and scientific presentations

Spinal Cord Stimulation


A Prospective Evaluation of a Novel Fast-Acting Sub-perception SCS Therapy: FAST Study  
Saturday, July 16 at 9:07 am ET   
Americana 2  
Presented by: Jennifer Lee, MD  

Artificial Intelligence-Driven Closed-Loop SCS:  Early Patient Feedback on Personalized Therapy Recommendations from a Digital Health Assistant 
Rauck et al.  

Enhanced Efficiency and Clinical Outcomes Using Fast-Acting Sub-perception Therapy (FAST) 
North et al.  

Improved Outcomes and Pain Relief Using Novel Fast-Acting Sub-Perception SCS 
Ferro et al.  

Long-Term Chronic Pain-Relief Outcomes Using an SCS System Capable of Combination Therapy 
Metzger et al.  

Real World Outcomes Using a Novel SCS Device Capable of Engaging Multiple Sub-perception Mechanisms  
Metzger et al.  

Utilization of Fast-Acting Sub-Perception Therapy (FAST) in SCS-Implanted Patients for Mixed Nociceptive and Neuropathic Pain 
Matis et al. 

Radiofrequency Ablation


RAPID: An International, Prospective, Multicenter Study of Radiofrequency Ablation Outcomes in Chronic Pain Patients
Friday, July 15 at 10:30 am ET   
Americana 2  
Presented by: Louis Raso, MD 

Treatment of Chronic Knee Pain Using Radiofrequency Ablation: Multicenter, Real-World Observational Study  
Atallah et al. 

The Vertiflex Procedure


Biomechanical Impact of Interspinous Spacers on Sagittal Alignment in Patients with Lumbar Spinal Stenosis 
Friday, July 15 at 10:37 am ET   
Americana 2  
Presented by: Peter Whang, MD, FACS 

Clinical Outcomes in a Highly Comorbid Population Using Interspinous Spacers for the Treatment of Lumbar Spinal Stenosis  
Naidu et al.  

Real World Evaluation of Patients Using an Interspinous Spacer for the Treatment of Lumbar Spinal Stenosis 
Esposito et al.  

Treating Symptomatic Adjacent Segment Disease After Lumbar Spinal Fusion with Interspinous Spacers: A Multicenter Observational Case Series 
Mehta et al. 

Superion™ Indirect Decompression System

 

MRI conditional symbol.

The WaveWriter Alpha™ SCS System provides safe access to full-body MRI scans when used with specific components and the patient is exposed to the MRI environment under the defined conditions in the ImageReady™ MRI Full Body Guidelines for WaveWriter Alpha and WaveWriter Alpha Prime Spinal Cord Stimulator System. 

Indications for Use. The Boston Scientific Spinal Cord Stimulator Systems are indicated as an aid in the management of chronic intractable pain of the trunk and/or limbs including unilateral or bilateral pain associated with the following: failed back surgery syndrome, Complex Regional Pain Syndrome (CRPS) Types I and II, intractable low back pain and leg pain.  Associated conditions and etiologies may be: radicular pain syndrome, radiculopathies resulting in pain secondary to failed back syndrome or herniated disc, epidural fibrosis, degenerative disc disease (herniated disc pain refractory to conservative and surgical interventions), arachnoiditis, multiple back surgeries. Contraindications, warnings, precautions, side effects. The SCS Systems are contraindicated for patients who: are unable to operate the SCS System, have failed trial stimulation by failing to receive effective pain relief, are poor surgical candidates, or are pregnant. Refer to the Instructions for Use provided with the SCS System or Pain.com for potential adverse effects, warnings, and precautions prior to using this product. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician. 

www.AlphaSCS.com  

Indications for Use. The Superion™ Indirect Decompression System (IDS) is indicated to treat skeletally mature patients suffering from pain, numbness, and/or cramping in the legs (neurogenic intermittent claudication) secondary to a diagnosis of moderate degenerative  lumbar spinal stenosis, with or without Grade 1 spondylolisthesis, having radiographic evidence of thickened ligamentum flavum, narrowed lateral recess, and/or central canal or foraminal narrowing. The Superion™ Interspinous Spacer is indicated for those patients with impaired physical function who experience relief in flexion from symptoms of leg/buttock/groin pain, with or without back pain, who have undergone at least 6 months of non-operative treatment.  The Superion Interspinous Spacer may be implanted at one or two adjacent lumbar levels in patients in whom treatment is indicated at no more than two levels, from L1 to L5. Contraindications, warnings, precautions, side effects. The Superion Indirect Decompression System (IDS) is contraindicated for patients who: have spinal anatomy that prevent implantation of the device or cause the device to be unstable in situ (i.e., degenerative spondylolisthesis greater than grade 1), Cauda equina syndrome, or prior decompression or fusion at the index level. Refer to the Instructions for Use provided on www.vertiflex.com for additional Indications for Use, contraindications information and potential adverse effects, warnings, and precautions prior to using this product. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician. 

https://www.bostonscientific.com/en-US/products/indirect-decompression-system/superion-indirect-decompression-system/instructions-for-use.html  

The Boston Scientific Radiofrequency Generators, associated Radiofrequency Lesion Probes and RF Cannula are indicated for use in procedures to create radiofrequency lesions for the treatment of pain or for lesioning only peripheral nerve tissue for functional neurosurgical procedures. The Boston Scientific RF Injection Electrodes are used for percutaneous nerve blocks with local anesthetic solution for radiofrequency lesioning of peripheral nerve tissue only. The Boston Scientific LCED and Stereotactic TCD Electrodes are indicated for use in radiofrequency (RF) heat lesioning of nervous tissue including the Central Nervous System. Warnings: The Boston Scientific RF devices may cause interference with active devices such as neurostimulators, cardiac pacemakers, and defibrillators. Interference may affect the action of these active devices or may damage them. For appropriate guidance, consult the instructions for use for these active devices. Caution: U.S. Federal law restricts this device to sale by or on the order of a physician. 

https://www.bostonscientific.com/en-US/products/nerve-radio-frequency-ablation/g4-rf-indications-of-use.html